Brendan Harley, CCIL Research Program Leader and Professor of Chemical and Biomolecular Engineering, is studying glioblastoma, an aggressive form of brain cancer. In collaboration with other researchers, Harley’s lab is developing platforms to help scientists better understand glioblastoma and create improved cancer treatments.